• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS205
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Pain (1994)
Event Type  Injury  
Event Description
This spontaneous case was originally reported by a lawyer on behalf of a consumer and describes the occurrence of pelvic pain ("severe long pelvic pain") in an adult female patient who had essure (ess205) inserted.Additional non-serious events are detailed below.Product or product use issues identified: device failure, defect ("failure defect (incl other organ damage)").There was no information on the patient's medical history or concurrent conditions.In (b)(6) 2004, the patient had essure (ess205) inserted.An unknown time later she experienced pelvic pain (seriousness criterion intervention required), injury ("failure defect (incl other organ damage)"), sexual dysfunction ("severe long sexual dysfunction") and mental disorder ("unspecified psych injury").The patient was treated with surgery (hysterectomy (laparoscopic)).Essure (ess205) was removed.The reporter considered injury, mental disorder, pelvic pain and sexual dysfunction to be related to essure (ess205) administration.The reporter commented: intention to remove the essure device.On (b)(6) 2023 essure removal was reported.Also stated that essure had impact on lifestyle.Quality-safety evaluation of ptc: for essure (ess205): unable to confirm complaint.The most recent follow-up information incorporated above includes data received on: 01-feb-2023: the correct ird is (b)(6) 2023.As reported events pelvic pain and sexual disfunction updated, added unspecified psych injury.Essure removal surgery reported so case was upgraded to serious incident.Based on the available information, a review of our complaint records and other relevant data was conducted; any new and reportable information that becomes available from our investigation will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd, p.o. box 915
whippany, nj 
MDR Report Key16399011
MDR Text Key309866444
Report Number2951250-2023-00547
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 02/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS205
Date Manufacturer Received02/01/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-